<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862288</url>
  </required_header>
  <id_info>
    <org_study_id>API/2011/23</org_study_id>
    <nct_id>NCT02862288</nct_id>
  </id_info>
  <brief_title>Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.</brief_title>
  <acronym>TherMO</acronym>
  <official_title>Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this work were to assess the feasibility, efficacy, short-term outcome and safety&#xD;
      of microwave ablation in the treatment of malignant bone, lung and renal tumors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor necrosis rate in post-intervention over one month monitoring period.</measure>
    <time_frame>one month</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Lung Tumor</condition>
  <condition>Bone Tumor</condition>
  <condition>Renal Tumor</condition>
  <arm_group>
    <arm_group_label>Renal tumor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microwave ablation of renal tumor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lung tumor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microwave ablation of lung tumor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bone tumor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microwave ablation of bone tumor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microwave ablation with Acculis Accu2i pMTA Applicator</intervention_name>
    <arm_group_label>Bone tumor</arm_group_label>
    <arm_group_label>Lung tumor</arm_group_label>
    <arm_group_label>Renal tumor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women &gt; 18 years old&#xD;
&#xD;
          -  Thermoablation indication of renal neoplasia, bone or lung decided during a&#xD;
             multidisciplinary consultation meeting - Generally speaking, the indications are: (i)&#xD;
             inoperable primary malignant tumor or secondary malignant tumor, (ii) resectable&#xD;
             primary malignant renal and lung tumor with medical contraindication to surgery or&#xD;
             general anesthesia&#xD;
&#xD;
          -  Signature of informed consent for participation&#xD;
&#xD;
          -  Affiliation to a social security scheme or French beneficiary of such a regime.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to percutaneous thermoablation&#xD;
&#xD;
          -  Renal or lung tumor up to 4 cm&#xD;
&#xD;
          -  Women of childbearing age, premenopausal, non-sterilized surgically, and unwilling to&#xD;
             use effective contraception&#xD;
&#xD;
          -  Legal incapacity or legal capacity limited&#xD;
&#xD;
          -  Person unlikely to cooperate in the study and / or low degree of cooperation expected&#xD;
             by the investigator&#xD;
&#xD;
          -  Person without health insurance&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sébastien Aubry, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre hospitalier régional universitaire de Besançon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 1, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

